| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999048004A1 Sram bus architecture and interconnect to an fpga |
| 09/23/1999 | WO1999047934A2 Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins) |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | WO1999047923A2 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 09/23/1999 | WO1999047921A1 CO-EXPRESSION OF Gia PROTEIN AND Gi PROTEIN COUPLED RECEPTOR TO ENHANCE SIGNAL TRANSDUCTION RESPONSES |
| 09/23/1999 | WO1999047697A1 Novel molecules of the g protein-coupled heptahelical receptor superfamily and uses therefor |
| 09/23/1999 | WO1999047689A2 Inhibitors of apoptosis proteins in plants |
| 09/23/1999 | WO1999047688A1 Inhibitors of apoptosis proteins in plants |
| 09/23/1999 | WO1999047683A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | WO1999047682A1 Adp-glucose transporter complex of the amyloplast |
| 09/23/1999 | WO1999047681A1 Adp-glucose transporter of the amyloplast |
| 09/23/1999 | WO1999047680A1 Mutant recombinant allergens |
| 09/23/1999 | WO1999047679A2 Genetic engineering salt tolerance in crop plants |
| 09/23/1999 | WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
| 09/23/1999 | WO1999047676A1 Human leupaxin polypeptide and dna encoding it, their uses |
| 09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047671A2 Dna sequences encoding semaphorin-h and diagnosis of metastatic cancer |
| 09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
| 09/23/1999 | WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors |
| 09/23/1999 | WO1999047668A2 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances |
| 09/23/1999 | WO1999047667A1 Human sec61 gamma subunit gene: cbdame07 |
| 09/23/1999 | WO1999047664A1 The human mitochondrial proteolipid mp68 homolog gene: cbnaac01 |
| 09/23/1999 | WO1999047663A1 Human h-beta 58 gene (cblalc05) |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047661A2 Production of biofilaments in transgenic animals |
| 09/23/1999 | WO1999047660A1 Retroviral packaging cell line |
| 09/23/1999 | WO1999047659A1 Use of human serum resistant vector particles and cell lines for human gene therapy |
| 09/23/1999 | WO1999047658A1 The cytokine family member ef-7 |
| 09/23/1999 | WO1999047657A2 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles |
| 09/23/1999 | WO1999047656A2 Nucleic acid binding proteins |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047654A2 Combination of genes for regulating flowering induction in useful and ornamental plants |
| 09/23/1999 | WO1999047646A1 Processes for improved presentation of antigens by dendritic cells |
| 09/23/1999 | WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | WO1999047640A1 Method for identifying proteases, protease target sites and regulators of protease activity in cells |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047638A2 Mutations in mitotic check point genes and methods of diagnosis |
| 09/23/1999 | WO1999047566A1 Synthetic peptides that enhance ldl uptake |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047563A2 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047562A1 Nephrin gene and protein |
| 09/23/1999 | WO1999047561A1 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047558A2 T cell costimulatory proteins, sequences and uses thereof |
| 09/23/1999 | WO1999047557A2 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins |
| 09/23/1999 | WO1999047556A2 Novel heparin-induced ccn-like molecules and uses therefor |
| 09/23/1999 | WO1999047555A1 Secreted proteins and polynucleotides encoding them |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design |
| 09/23/1999 | WO1999047552A2 Genes encoding mlo proteins and conferring fungal resistance upon plants |
| 09/23/1999 | WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 09/23/1999 | WO1999047544A1 nrdF |
| 09/23/1999 | WO1999047540A1 95 human secreted proteins |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 09/23/1999 | WO1999047177A1 Gene therapy vector with osteocalcin promoter and genes for bone morphogenic proteins or growth factors |
| 09/23/1999 | WO1999047167A1 Double mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047165A1 Production of purified mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047161A1 Human appetite control by glucagon-like peptide receptor binding compounds |
| 09/23/1999 | WO1999047158A2 Therapeutic chemokine receptor antagonists |
| 09/23/1999 | WO1999047151A1 Peptide ligands for the erythropoietin receptor |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999047070A1 Improved implantable biomaterials, compositions and methods for their preparation and uses thereof |
| 09/23/1999 | WO1999046976A1 Plant promoter sequences and methods of use thereof |
| 09/23/1999 | WO1999041379A3 Members of the d52 gene family |
| 09/23/1999 | WO1999041374A3 Human short-chain tnf-receptor family protein |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999041355A3 Hiv chemokines |
| 09/23/1999 | WO1999041273A3 Pna and dna conjugates and methods for preparation thereof |
| 09/23/1999 | WO1999040112A8 Neuroprotective peptides and uses thereof |
| 09/23/1999 | WO1999038975A3 Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof |
| 09/23/1999 | WO1999038955A3 Mutant herpes simplex viruses and uses thereof |
| 09/23/1999 | WO1999037774A8 Differentiation-associated sequences and methods of use therefor |
| 09/23/1999 | WO1999036558A3 Viral vectors encoding neurofilament heavy proteins and their use |
| 09/23/1999 | WO1999036533A3 Nucleic acid corresponding to mutation associated with cholestasis syndromes |
| 09/23/1999 | WO1999036528A3 Transgenic non-human mammal, a method for the production thereof, and the utilization thereof |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | WO1999029719A3 Pancreatic-derived factors, and uses related thereto |
| 09/23/1999 | WO1999028876A3 Hydrophobically-modified protein compositions and methods |
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | WO1999025733A3 SUBSTANCES TARGETED TO THE ACTIVE SITE OF THE FtsH PROTEIN, DNA ENCODING SAID SUBSTANCES AND USES THEREOF |
| 09/23/1999 | DE19841413C1 New potassium channel protein, Kv6.2, used to screen for specific modulators, potentially useful e.g. as antiarrhythmic agents |
| 09/23/1999 | DE19825395C1 New antiviral RNA that binds specifically to a picorna virus protein, for preventing rhinovirus, polio and Coxsackie virus infections |
| 09/23/1999 | DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy |
| 09/23/1999 | DE19758545A1 Verfahren zur Untersuchung der Eigenschaften von Neurotransmitter-Rezeptoren A method for investigating the properties of neurotransmitter receptors |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2324520A1 Plant promoter sequences and methods of use thereof |
| 09/23/1999 | CA2324504A1 Secreted proteins and polynucleotides encoding them |
| 09/23/1999 | CA2324453A1 Combination of genes for regulating flowering induction in useful and ornamental plants |
| 09/23/1999 | CA2324080A1 Co-expression of gia protein and gi protein coupled receptor to enhance signal transduction responses |
| 09/23/1999 | CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 09/23/1999 | CA2323761A1 95 human secreted proteins |
| 09/23/1999 | CA2323746A1 T cell costimulatory proteins, sequences and uses thereof |